Vaccination status and attitudes towards COVID-19 vaccination in patients undergoing active cancer treatment in a referral center in Mexico: a survey study
BA Martinez-Cannon, K Garcia-Ronquillo… - Supportive Care in …, 2023 - Springer
Background COVID-19 vaccination refusal/hesitancy among patients with cancer has been
reported to be high. This study aimed to assess vaccination status and attitudes towards …
reported to be high. This study aimed to assess vaccination status and attitudes towards …
Risk of waning humoral responses after inactivated or subunit recombinant SARS‐CoV‐2 vaccination in patients with chronic diseases: Findings from a prospective …
H Li, D Cai, D Jiang, X Li, X Liao, D Liu… - Journal of medical …, 2023 - Wiley Online Library
Heterogeneity of antibody responses has been reported in SARS‐CoV‐2 vaccination
recipients with underlying diseases. We investigated the impact of the presence of …
recipients with underlying diseases. We investigated the impact of the presence of …
Bibliometric analysis of scientific papers on adverse reactions to COVID-19 vaccines published between 2019 and 2023
X Yang, M Chen, L Cao, M Zhao - Human Vaccines & …, 2023 - Taylor & Francis
ABSTRACT The Coronavirus Disease 2019 (COVID-19) pandemic has now persisted
globally for four years, resulting in a staggering death toll of over 4 million individuals. The …
globally for four years, resulting in a staggering death toll of over 4 million individuals. The …
Dynamic antibody response in SARS-CoV-2 infected patients and COVID-19 vaccine recipients alongside vaccine effectiveness in comorbid and multimorbid groups
D Das, FK Raha, KM Adnan, MR Siraj, MJ Shapla… - Heliyon, 2023 - cell.com
Objectives Underlying medical conditions are critical risk factors for COVID-19 susceptibility
and its rapid clinical manifestation. Therefore, the preexisting burden of non-communicable …
and its rapid clinical manifestation. Therefore, the preexisting burden of non-communicable …
[HTML][HTML] COVID-19 vaccination in cancer patients: Immune responses one year after the third dose
R Campagna, F Dominelli, MA Zingaropoli, F Ciurluini… - Vaccine, 2024 - Elsevier
Cancer patients (CPs), being immunosuppressed due to the treatment received or to the
disease itself, are more susceptible to infections and their potential complications, showing …
disease itself, are more susceptible to infections and their potential complications, showing …
Vaccinazione anti SARS-CoV-2 in popolazioni''fragili'': studio di alcune componenti della risposta immunitaria
R Campagna - 2024 - iris.uniroma1.it
Abstract SARS-CoV-2 (Severe Acute Respiratory Syndrome Coronavirus 2) è l'agente
eziologico della malattia COVID-19 (Coronavirus Disease 2019) responsabile dello stato di …
eziologico della malattia COVID-19 (Coronavirus Disease 2019) responsabile dello stato di …